Scotiabank Has Negative Estimate for TSE:ATR FY2027 Earnings

SNC-Lavalin Group Inc. (TSE:ATR) – Investment analysts at Scotiabank decreased their FY2027 EPS estimates for SNC-Lavalin Group in a research note issued to investors on Wednesday, May 20th. Scotiabank analyst J. Goldman now forecasts that the company will earn $4.39 per share for the year, down from their prior estimate of $4.60.

SNC-Lavalin Group Stock Performance

SNC-Lavalin Group Company Profile

AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions.